European Best Practice Guidelines 14–16 Inadequate response to epoetin

التفاصيل البيبلوغرافية
العنوان: European Best Practice Guidelines 14–16 Inadequate response to epoetin
المؤلفون: Walter H. Hörl, Bruce G. Carveth, Fernando Valderrábano, Iain C. Macdougall, Ima Parrondo, Claude Jacobs, Karen Thompson
المصدر: Nephrology Dialysis Transplantation. 15:43-50
بيانات النشر: Oxford University Press (OUP), 2000.
سنة النشر: 2000
مصطلحات موضوعية: Transplantation, medicine.medical_specialty, Anemia, business.industry, medicine.medical_treatment, medicine.disease, Gastroenterology, Peritoneal dialysis, Dose–response relationship, Endocrinology, Nephrology, Erythropoietin, Concomitant, Internal medicine, Toxicity, Cohort, medicine, business, Kidney disease, medicine.drug
الوصف: (n=370), comparative analyses would be inappropriResults ate. For the group of ‘high-dose’ patients, only 31.4% had haemoglobin levels of 11.0 g/dl; 29.7% had levels Key points from the EBPG between 10.0 and 10.9 g/dl, 21.1% between 9.0 and 9.9 g/dl, and the remaining 17.8% below 9.0 g/dl $ A need for >300 IU/kg/weekly epoetin defines an (Figure 39). The mean serum ferritin level was inadequate response (‘resistance’). 481.2 mg/l (SD=472.9) and the mean transferrin $ Iron deficiency (absolute or functional ) is the most saturation (TSAT) was 25.1% (SD=13.2). Of 313 common cause of an inadequate response to patients for whom serum ferritin values were available, epoetin although patients must be screened for 36 (11.5%) had levels
تدمد: 1460-2385
0931-0509
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9b138e3b08fe9eb84cb7a60b2454d725
https://doi.org/10.1093/ndt/15.suppl_4.43
رقم الأكسشن: edsair.doi...........9b138e3b08fe9eb84cb7a60b2454d725
قاعدة البيانات: OpenAIRE